Ellevest, Inc. Moderna, Inc. Transaction History

Ellevest, Inc.

$1.66 Billion
Q2 2024

A detailed history of Ellevest, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Ellevest, Inc. holds 2,293 shares of MRNA stock, worth $150,764. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,293

Previous 1,928 18.93%

Holding current value

$150,764

Previous $205,000 32.68%

% of portfolio

0.02%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $36,941 - $60,812	365 Added 18.93%	2,293 $272,000
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $164,593 - $222,568	1,928 New	1,928 $205,000
Q1 2023 May 04, 2023	BUY	$135.66 - $197.02 $2,306 - $3,349	17 Added 1.56%	1,105 $169,000
Q4 2022 Feb 03, 2023	BUY	$118.38 - $210.04 $42,971 - $76,244	363 Added 50.07%	1,088 $195,000
Q3 2022 Nov 02, 2022	SELL	$118.07 - $194.18 $7,792 - $12,815	-66 Reduced 8.34%	725 $86,000
Q2 2022 Jul 18, 2022	BUY	$117.13 - $176.59 $5,622 - $8,476	48 Added 6.46%	791 $113,000
Q1 2022 Apr 19, 2022	BUY	$126.46 - $235.05 $30,350 - $56,412	240 Added 47.71%	743 $128,000
Q4 2021 Jan 24, 2022	BUY	$225.82 - $368.51 $108,845 - $177,621	482 Added 2295.24%	503 $128,000
Q3 2021 Oct 19, 2021	BUY	$221.9 - $484.47 $4,659 - $10,173	21 New	21 $8,000
Q3 2020 Oct 26, 2020	SELL	$54.34 - $94.85 $1,358 - $2,371	-25 Closed	0 $0
Q2 2020 Jul 06, 2020	SELL	$29.67 - $80.0 $326 - $880	-11 Reduced 30.56%	25 $2,000
Q1 2020 Apr 13, 2020	SELL	$17.78 - $31.58 $213 - $378	-12 Reduced 25.0%	36 $1,000
Q4 2019 Feb 05, 2020	BUY	$13.93 - $21.28 $668 - $1,021	48 New	48 $1,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account